PR Newswire UK Disclose - LILLY (ELI) & COMPANY - Cymbalta Reduced Pain in Fibromyalgia Patients.
Related Results
Lilly prepares for Cymbalta launch
Duloxetine lifts arthritis pain, aids cognition.(Psychosomatic Medicine)
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized An…
FDA Approves Cymbalta(R) for Treatment of Generalized Anxiety Disorder
Duloxetine improves depression, pain, cognition.
re>
Date: August 21, 2007
For Release: Immediately
Refer to: Sonja Popp-Stahly (US), 317-655-2993, mobile: 317-437-9947,
spopp-stahly@lilly.com
David Shaffer (OUS), 317-651-3710, djshaffer@lilly.com
New Data Suggest CymbaltaA[R] Reduced Pain in Fibromyalgia Patients
With and Without Depression
INDIANAPOLIS - New data suggest that patients with fibromyalgia treated with
60mg or 120mg of CymbaltaA[R] (duloxetine HCl) experienced greater reduction in
pain severity beginning one week after starting duloxetine than those taking
placebo (sugar …
Read the rest of this article with a Free Trial at HighBeam Research.
